Kerala Ayurveda Ltd

While broader indices have shown resilience, Kerala Ayurveda Ltd has succumbed to persistent selling pressure, hitting a fresh 52-week low of Rs 148.65 on 24 Jul 2026. The stock’s decline contrasts sharply with the market’s attempts at recovery, underscoring company-specific headwinds that continue to weigh on investor sentiment.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 July 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Kerala Ayurveda Ltd., the speciality ayurvedic medicines manufacturer, reported a consolidated net loss of ₹7.76 crores for Q4 FY26, marking a deterioration of 74.38% quarter-on-quarter and a staggering 50.06% decline year-on-year. The company, with a market capitalisation of ₹272.00 crores, continues to grapple with severe operational challenges that have eroded profitability despite modest revenue growth. Shares have plummeted 48.15% over the past year, trading at ₹211.00 as investors flee amidst mounting concerns about the company's financial viability.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 May 2026, providing investors with the latest insights into its performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Despite a broader market recovery, Kerala Ayurveda Ltd has plunged to a fresh 52-week low of Rs 150 on 30 Mar 2026, extending its recent losing streak and underperforming its sector by 2.79% today.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Kerala Ayurveda Ltd’s shares touched a fresh 52-week low of Rs.161.05 today, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. Despite a volatile trading session, the stock remains below all key moving averages, reflecting persistent downward momentum.

Kerala Ayurveda Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.162 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and market performance.

Kerala Ayurveda Ltd’s shares fell sharply to a new 52-week low of Rs.163.7 on 13 Mar 2026, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its peers and broader market indices, reflecting persistent financial and market challenges.